CXCL11 Signaling in the Tumor Microenvironment

Adv Exp Med Biol. 2021;1302:41-50. doi: 10.1007/978-3-030-62658-7_4.ABSTRACTCXCL11 which can bind to two different chemokine receptors, CXCR3 and CXCR7, has found a prominent place in current tumor research. In this chapter, we mainly discuss the current evidence on the role of the immune response of CXCL11 in tumor microenvironment (TME). The diverse functions of CXCL11 include inhibiting angiogenesis, affecting the proliferation of different cell types, playing a role in fibroblast directed carcinoma invasion, increasing adhesion properties, suppressing M2 macrophage polarization, and facilitating the migration of certain immune cells. In addition, we discussed the application of CXCL11 as an adjuvant to various mainstream anti-cancer therapies and the future challenges in the application of CXCL11 targeted therapies.PMID:34286440 | DOI:10.1007/978-3-030-62658-7_4
Source: Advances in Experimental Medicine and Biology - Category: Research Authors: Source Type: research